NCT06683235View on ClinicalTrials.gov

Effect of Flaxseed as a Treatment for Adults With Type 2 Diabetes Mellitus in Mexico

NAEnrolling by invitationINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2025

Conditions
DIABETES Mellitus Type 2 Not Well Controlled
Interventions
DIETARY_SUPPLEMENT

flaxseed

Participants in the intervention group will be given 16 g of ground flaxseed per day for 3 months.

Trial Locations (1)

68024

Hospital Regional Presidente Juárez, Oaxaca City

All Listed Sponsors
lead

Universidad Autónoma Benito Juárez de Oaxaca

OTHER